INNOVATE CorpVATE
VATE
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
32% more capital invested
Capital invested by funds: $8.91M [Q3] → $11.8M (+$2.86M) [Q4]
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
0.49% less ownership
Funds ownership: 18.45% [Q3] → 17.96% (-0.49%) [Q4]
15% less funds holding
Funds holding: 34 [Q3] → 29 (-5) [Q4]
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 [Q3] → 0 (-1) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for VATE.
Financial journalist opinion
Neutral
Seeking Alpha
17 hours ago
INNOVATE Corp. (VATE) Q4 2024 Earnings Call Transcript
INNOVATE Corp. (NYSE:VATE ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants Neel Sikka - Investor Relations Paul Voigt - Interim Chief Executive Officer Mike Sena - Chief Financial Officer Conference Call Participants Brian Charles - R.W. Pressprich Operator Good afternoon and welcome to INNOVATE Corp's Fourth Quarter and Full Year 2024 Earnings Conference Call.
Neutral
GlobeNewsWire
1 day ago
INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results
- Infrastructure: DBM Global fourth quarter revenue of $225.7 million - - Life Sciences: MediBeacon ® Transdermal GFR (“TGFR”) system received FDA approval to assess kidney function - - Spectrum: Broadcasting achieved double-digit revenue growth in the fourth quarter and full year 2024 -
Neutral
GlobeNewsWire
1 month ago
INNOVATE Corp. to Report Fourth Quarter and Full Year 2024 Results on March 31st
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the fourth quarter and full year 2024 on Monday, March 31, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET.
Neutral
GlobeNewsWire
1 month ago
MediBeacon® Transdermal GFR System receives device approval in China
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The Clinical Kidney Journal in February published MediBeacon study results on measured GFR (mGFR) using relmapirazin versus estimated GFR (eGFR) for the purpose of classifying patient Chronic Kidney Disease (CKD) stages.
Neutral
GlobeNewsWire
2 months ago
MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) has approved the MediBeacon® TGFR for the assessment of kidney function in patients with normal or impaired renal function.
Neutral
GlobeNewsWire
4 months ago
INNOVATE Corp. Portfolio Company R2 Technologies Announces Another Record-Breaking Quarter and Partnerships with Woodhouse Spas and Top Skincare Brands
NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- R2 Technologies, Inc., the world leader in CryoAesthetics® with its cutting-edge Glacial Skin systems (“R2”), a portfolio company of INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it has achieved several impressive milestones during 2024. The growing momentum of the brand coupled with recent key partnerships has positioned the company for substantial growth across the aesthetics and wellness sectors.
Neutral
Seeking Alpha
4 months ago
INNOVATE Corp. (VATE) Q3 2024 Earnings Call Transcript
INNOVATE Corp. (VATE) Q3 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
4 months ago
INNOVATE Corp. Announces Third Quarter 2024 Results
- Infrastructure: DBM Global third quarter revenue of $232.8 million - - Life Sciences: R2 reports record worldwide system unit sales growth in the third quarter - - Spectrum: Broadcasting's delivered another quarter of strong growth driven by network launches -
Neutral
GlobeNewsWire
5 months ago
INNOVATE Corp. to Report Third Quarter 2024 Results on November 6th
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the third quarter 2024 on Wednesday, November 6, 2024, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET.
Neutral
GlobeNewsWire
6 months ago
INNOVATE Corp. Regains Compliance with NYSE Minimum Price Requirement
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it has received a letter from the New York Stock Exchange (“NYSE”) dated August 27, 2024 (the “Compliance Notice”), notifying the Company that it is no longer considered below the NYSE's continued listing criterion of a minimum average share price of US $1.00 over a 30 trading-day period (the "NYSE Minimum Price Requirement").
Charts implemented using Lightweight Charts™